Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Lindahl

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|February 10, 2021
Inflammatory Depression-Mechanisms and Non-Pharmacological InterventionsKlara Suneson, Jesper Lindahl, Simon Chamli Hårsmar, et al.
BMC Psychiatry|December 19, 2022
Efficacy of eicosapentaenoic acid in inflammatory depression: study protocol for a match-mismatch trialKlara Suneson, Filip Ängeby, Jesper Lindahl, et al.
Psychiatric Research and Clinical Practice|October 13, 2022
Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic DepressionFilip Ventorp, Jesper Lindahl, Danielle van Westen, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 29, 2025
A plasma protein profile of antidepressant response to omega-3 fatty acidsJesper Lindahl, Miranda Stiernborg, Filip Ventorp, et al.
Brain, Behavior, & Immunity - Health|April 13, 2026
Kynurenine pathway metabolites are increased in inflammatory depression and decrease with omega-3 treatmentJesper Lindahl, Gustav Söderberg Veibäck, Klara Suneson, et al.
Brain, Behavior, and Immunity|February 25, 2025
Corrigendum to "Omega-3 fatty acids for inflamed depression - A match/mismatch study" [Brain Behav. Immun. 118 (2024) 192-201]Klara Suneson, Gustav Söderberg Veibäck, Jesper Lindahl, et al.
Brain, Behavior, and Immunity|March 3, 2024
Omega-3 fatty acids for inflamed depression - A match/mismatch studyKlara Suneson, Gustav Söderberg Veibäck, Jesper Lindahl, et al.
Brain, Behavior, and Immunity|June 8, 2025
Add-on probiotics for inflammatory depression - A double-blind randomized placebo-controlled trialGustav Söderberg Veibäck, Jesper Lindahl, Klara Suneson, et al.
BMJ Open|November 30, 2023
Add-on pramipexole for anhedonic depression: study protocol for a randomised controlled trial and open-label follow-up in Lund, SwedenJesper Lindahl, Marie Asp, Darya Ståhl, et al.
Nature Medicine|June 12, 2026
Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trialFilip Ventorp, Marie Asp, Sofia Olsson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|February 10, 2021
Inflammatory Depression-Mechanisms and Non-Pharmacological InterventionsKlara Suneson, Jesper Lindahl, Simon Chamli Hårsmar, et al.
BMC Psychiatry|December 19, 2022
Efficacy of eicosapentaenoic acid in inflammatory depression: study protocol for a match-mismatch trialKlara Suneson, Filip Ängeby, Jesper Lindahl, et al.
Psychiatric Research and Clinical Practice|October 13, 2022
Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic DepressionFilip Ventorp, Jesper Lindahl, Danielle van Westen, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 29, 2025
A plasma protein profile of antidepressant response to omega-3 fatty acidsJesper Lindahl, Miranda Stiernborg, Filip Ventorp, et al.
Brain, Behavior, & Immunity - Health|April 13, 2026
Kynurenine pathway metabolites are increased in inflammatory depression and decrease with omega-3 treatmentJesper Lindahl, Gustav Söderberg Veibäck, Klara Suneson, et al.
Brain, Behavior, and Immunity|February 25, 2025
Corrigendum to "Omega-3 fatty acids for inflamed depression - A match/mismatch study" [Brain Behav. Immun. 118 (2024) 192-201]Klara Suneson, Gustav Söderberg Veibäck, Jesper Lindahl, et al.
Brain, Behavior, and Immunity|March 3, 2024
Omega-3 fatty acids for inflamed depression - A match/mismatch studyKlara Suneson, Gustav Söderberg Veibäck, Jesper Lindahl, et al.
Brain, Behavior, and Immunity|June 8, 2025
Add-on probiotics for inflammatory depression - A double-blind randomized placebo-controlled trialGustav Söderberg Veibäck, Jesper Lindahl, Klara Suneson, et al.
BMJ Open|November 30, 2023
Add-on pramipexole for anhedonic depression: study protocol for a randomised controlled trial and open-label follow-up in Lund, SwedenJesper Lindahl, Marie Asp, Darya Ståhl, et al.
Nature Medicine|June 12, 2026
Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trialFilip Ventorp, Marie Asp, Sofia Olsson, et al.
Pageof 1